These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27417956)

  • 21. Molecular analysis of Frasier syndrome: mutation in the WT1 gene in a girl with gonadal dysgenesis and nephronophthisis.
    Pérez de Nanclares G; Castaño L; Bilbao JR; Vallo A; Rica I; Vela A; Martul P
    J Pediatr Endocrinol Metab; 2002; 15(7):1047-50. PubMed ID: 12199335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development.
    Natoli TA; Liu J; Eremina V; Hodgens K; Li C; Hamano Y; Mundel P; Kalluri R; Miner JH; Quaggin SE; Kreidberg JA
    J Am Soc Nephrol; 2002 Aug; 13(8):2058-67. PubMed ID: 12138137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Denys-Drash syndrome. Experience gathered in Erlangen illustrated by two case reports].
    Zugor V; Zenker M; Dötsch J; Schrott KM; Schott GE
    Urologe A; 2005 Oct; 44(10):1197-200. PubMed ID: 16003530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.
    Klattig J; Sierig R; Kruspe D; Besenbeck B; Englert C
    Mol Cell Biol; 2007 Jun; 27(12):4355-64. PubMed ID: 17420277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report.
    Alge JL; Wenderfer SE; Hicks J; Bekheirnia MR; Schady DA; Kain JS; Braun MC
    BMC Nephrol; 2017 Jul; 18(1):243. PubMed ID: 28720077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WT1 Haploinsufficiency Supports Milder Renal Manifestation in Two Patients with Denys-Drash Syndrome.
    Guaragna MS; Ribeiro de Andrade JG; de Freitas Carli B; Belangero VM; Maciel-Guerra AT; Guerra-Júnior G; de Mello MP
    Sex Dev; 2017; 11(1):34-39. PubMed ID: 28081536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional regulation of PDGF-A and TGF-beta by +KTS WT1 deletion mutants and a mutant mimicking Denys-Drash syndrome.
    Jin DK; Kang SJ; Kim SJ; Bang EH; Hwang HZ; Tadokoro K; Yamada M; Kohsaka T
    Ren Fail; 1999 Nov; 21(6):685-94. PubMed ID: 10586431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repression of CMIP transcription by WT1 is relevant to podocyte health.
    Moktefi A; Zhang SY; Vachin P; Ory V; Henique C; Audard V; Rucker-Martin C; Gouadon E; Eccles M; Schedl A; Heidet L; Ollero M; Sahali D; Pawlak A
    Kidney Int; 2016 Dec; 90(6):1298-1311. PubMed ID: 27650733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report].
    Wasilewska A; Zoch-Zwierz W; Tenderenda E; Rybi-Szumińska A; Kołodziejczyk Z
    Pol Merkur Lekarski; 2009 Jun; 26(156):642-4. PubMed ID: 19711733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.
    da Silva TE; Nishi MY; Costa EM; Martin RM; Carvalho FM; Mendonca BB; Domenice S
    Pediatr Nephrol; 2011 Aug; 26(8):1311-5. PubMed ID: 21559934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glomerular epithelial cell phenotype in diffuse mesangial sclerosis: a report of 2 cases with markedly increased urinary podocyte excretion.
    Ikezumi Y; Suzuki T; Karasawa T; Kaneko U; Yamada T; Hasegawa H; Nagata M; Saitoh A
    Hum Pathol; 2014 Aug; 45(8):1778-83. PubMed ID: 24856573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WT1 splice site mutation in a 46,XX female with minimal-change nephrotic syndrome and Wilms' tumour.
    Loirat C; André JL; Champigneulle J; Acquaviva C; Chantereau D; Bourquard R; Elion J; Denamur E
    Nephrol Dial Transplant; 2003 Apr; 18(4):823-5. PubMed ID: 12637656
    [No Abstract]   [Full Text] [Related]  

  • 34. A female infant with Frasier syndrome showing splice site mutation in Wilms' tumor gene (WT1) intron 9.
    Fujita S; Sugimoto K; Miyazawa T; Yanagida H; Tabata N; Okada M; Takemura T
    Clin Nephrol; 2010 Jun; 73(6):487-91. PubMed ID: 20497763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome.
    Hakan N; Aydin M; Erdogan O; Cavusoglu YH; Aycan Z; Ozaltin F; Zenciroglu A; Apaydin S; Gunes R; Sahin G; Cinar G; Okumus N
    Genet Couns; 2012; 23(2):255-61. PubMed ID: 22876585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital diaphragmatic eventration with pulmonary dysplasia in Frasier syndrome due to a WT1 mutation of c.1432+5(IVS9)G>A.
    Zhang B; Ding Y; Ren X; Song C; Zhang X; Wang F; Yang X
    Eur J Med Genet; 2022 Dec; 65(12):104655. PubMed ID: 36341869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation.
    Davies JA; Ladomery M; Hohenstein P; Michael L; Shafe A; Spraggon L; Hastie N
    Hum Mol Genet; 2004 Jan; 13(2):235-46. PubMed ID: 14645201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and pathological features of Denys-Drash syndrome: report of 3 cases].
    Wang HY; Sun LZ; Yue ZH; Yang J; Jiang XY; Mo Y
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):855-8. PubMed ID: 23302619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WT1 gene mutation responsible for male sex reversal and renal failure: the Frasier syndrome.
    Saylam K; Simon P
    Eur J Obstet Gynecol Reprod Biol; 2003 Sep; 110(1):111-3. PubMed ID: 12932885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.
    Ratelade J; Arrondel C; Hamard G; Garbay S; Harvey S; Biebuyck N; Schulz H; Hastie N; Pontoglio M; Gubler MC; Antignac C; Heidet L
    Hum Mol Genet; 2010 Jan; 19(1):1-15. PubMed ID: 19797313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.